Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ticagrelor Versus Clopidogrel in Older Patients with NSTE-ACS Using Oral Anticoagulation: A Sub-Analysis of the POPular Age Trial.
Gimbel ME, Tavenier AH, Bor W, Hermanides RS, de Vrey E, Heestermans T, Gin MTJ, Waalewijn R, Hofma S, den Hartog F, Jukema W, von Birgelen C, Voskuil M, Kelder J, Deneer V, Ten Berg JM. Gimbel ME, et al. Among authors: deneer v. J Clin Med. 2020 Oct 12;9(10):3249. doi: 10.3390/jcm9103249. J Clin Med. 2020. PMID: 33053622 Free PMC article.
Clopidogrel resistance: fact and fiction.
van Werkum JW, Heestermans AA, Deneer VH, Hackeng CM, Ten Berg JM. van Werkum JW, et al. Among authors: deneer vh. Future Cardiol. 2006 Mar;2(2):215-28. doi: 10.2217/14796678.2.2.215. Future Cardiol. 2006. PMID: 19804078
Besides CYP2C19*2, the variant allele CYP2C9*3 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantation.
Harmsze A, van Werkum JW, Bouman HJ, Ruven HJ, Breet NJ, Ten Berg JM, Hackeng CM, Tjoeng MM, Klungel OH, de Boer A, Deneer VH. Harmsze A, et al. Pharmacogenet Genomics. 2010 Jan;20(1):18-25. doi: 10.1097/FPC.0b013e328333dafe. Pharmacogenet Genomics. 2010. PMID: 19934793
Combined influence of proton-pump inhibitors, calcium-channel blockers and CYP2C19*2 on on-treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention.
Harmsze AM, van Werkum JW, Souverein PC, Breet NJ, Bouman HJ, Hackeng CM, Ruven HJ, ten Berg JM, Klungel OH, de Boer A, Deneer VH. Harmsze AM, et al. Among authors: deneer vh. J Thromb Haemost. 2011 Oct;9(10):1892-901. doi: 10.1111/j.1538-7836.2011.04483.x. J Thromb Haemost. 2011. PMID: 21854540 Free article.
107 results